Paris

29, avenue d’Eylau
75 116 PARIS
tél. : +33 (0)1 53 70 05 55
fax : +33 (0)1 53 70 05 59

Lyon

55 rue RABELAIS
69003 LYON
tél. : +33 (0)1 53 70 05 55
fax : +33 (0)1 53 70 05 59

News

March 2016 : Sale of "Laboratoire HRA" to Goldman Sachs and Astorg

mars 2016

HRA Pharma’s founders and the Riverside Investment Fund have sold their shareholding in "Laboratoire HRA" to Goldman Sachs and Astorg. HRA is a leading pharmaceutical company specialized in the development and the marketing of innovative treatments for women’s health and endocrinology. It is established in 11 countries and its products marketed in 80 countries. Its founders and Riverside have kept a minority shareholding while Goldman Sachs and Astorg are the new majority shareholders.

P&A has assisted one of the founders in this transaction.